BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31012208)

  • 1. IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials.
    Chisholm KM; Mohlman J; Liew M; Termuhlen A; Cairo MS; Gross TG; Perkins SL; Miles RR
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27770. PubMed ID: 31012208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult population.
    Hesius EAM; van Laar L; Oosterveld M; van Spriel AB; Scheijen B; Leeuwis JW; Marres HAM; Groenen PJTA; Stevens WBC; van der Spek E; van den Brule AJC; Hoevenaars BM; Hebeda KM; van den Brand M
    Histopathology; 2023 Jun; 82(7):1013-1020. PubMed ID: 36779226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients.
    Yuan J; Liu H; Hu S; Miranda RN; Xu X; Bayerl MG; Artymiuk CJ; Berg H; King RL; Shi M; He R; Viswanatha D; Medeiros LJ; McPhail ED
    Hum Pathol; 2023 Nov; 141():22-29. PubMed ID: 37634651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual presentation of large B-cell lymphoma with interferon regulatory factor 4 gene rearrangement.
    Verma A; Epari S; Gujral S; Shet T
    Indian J Pathol Microbiol; 2018; 61(2):271-274. PubMed ID: 29676376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.
    Horn H; Schmelter C; Leich E; Salaverria I; Katzenberger T; Ott MM; Kalla J; Romero M; Siebert R; Rosenwald A; Ott G
    Haematologica; 2011 Sep; 96(9):1327-34. PubMed ID: 21659362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas.
    Salaverria I; Martin-Guerrero I; Burkhardt B; Kreuz M; Zenz T; Oschlies I; Arnold N; Baudis M; Bens S; García-Orad A; Lisfeld J; Schwaenen C; Szczepanowski M; Wessendorf S; Pfreundschuh M; Trümper L; Klapper W; Siebert R
    Genes Chromosomes Cancer; 2013 Feb; 52(2):150-5. PubMed ID: 23073988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell lymphoma with IRF4 rearrangement: A clinicopathological study of 13 cases.
    Zhou L; Gu B; Shen X; Binshen O; Dong L; Zhou J; Yi H; Wang C
    Pathol Int; 2021 Mar; 71(3):183-190. PubMed ID: 33503299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
    Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X
    J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
    Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
    Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group.
    Au-Yeung RKH; Arias Padilla L; Zimmermann M; Oschlies I; Siebert R; Woessmann W; Burkhardt B; Klapper W
    Br J Haematol; 2020 Sep; 190(5):753-763. PubMed ID: 32239695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tonsillar follicular large B-cell lymphoma with
    Yu YT; Sakata S; Takeuchi K; Medeiros LJ; Chang KC
    J Clin Pathol; 2020 Feb; 73(2):120. PubMed ID: 31324665
    [No Abstract]   [Full Text] [Related]  

  • 12. Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.
    Salaverria I; Philipp C; Oschlies I; Kohler CW; Kreuz M; Szczepanowski M; Burkhardt B; Trautmann H; Gesk S; Andrusiewicz M; Berger H; Fey M; Harder L; Hasenclever D; Hummel M; Loeffler M; Mahn F; Martin-Guerrero I; Pellissery S; Pott C; Pfreundschuh M; Reiter A; Richter J; Rosolowski M; Schwaenen C; Stein H; Trümper L; Wessendorf S; Spang R; Küppers R; Klapper W; Siebert R; ; ;
    Blood; 2011 Jul; 118(1):139-47. PubMed ID: 21487109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].
    Luo DL; Liu YH; Zhang F; Xu FP; Yan LX; Chen J; Xu J; Luo XL; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):584-8. PubMed ID: 24314242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
    Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
    [No Abstract]   [Full Text] [Related]  

  • 15. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.
    Ramis-Zaldivar JE; Gonzalez-Farré B; Balagué O; Celis V; Nadeu F; Salmerón-Villalobos J; Andrés M; Martin-Guerrero I; Garrido-Pontnou M; Gaafar A; Suñol M; Bárcena C; Garcia-Bragado F; Andión M; Azorín D; Astigarraga I; Sagaseta de Ilurdoz M; Sábado C; Gallego S; Verdú-Amorós J; Fernandez-Delgado R; Perez V; Tapia G; Mozos A; Torrent M; Solano-Páez P; Rivas-Delgado A; Dlouhy I; Clot G; Enjuanes A; López-Guillermo A; Galera P; Oberley MJ; Maguire A; Ramsower C; Rimsza LM; Quintanilla-Martinez L; Jaffe ES; Campo E; Salaverria I
    Blood; 2020 Jan; 135(4):274-286. PubMed ID: 31738823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma.
    Pon JR; Marra MA
    Blood; 2016 Jan; 127(2):181-6. PubMed ID: 26447189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Incidence and Clinical Significance of MYC Rearrangements in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.
    Schrader AMR; Jansen PM; Vermeer MH; Kleiverda JK; Vermaat JSP; Willemze R
    Am J Surg Pathol; 2018 Nov; 42(11):1488-1494. PubMed ID: 30113335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival of patients with primary central nervous system diffuse large B-cell lymphoma: impact of gene aberrations and protein overexpression of bcl-2 and C-MYC, and selection of chemotherapy regimens].
    Yin WJ; Zhu X; Yang HY; Sun WY; Wu MJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):32-38. PubMed ID: 29325248
    [No Abstract]   [Full Text] [Related]  

  • 19. Prognostic Significance of
    Rosenwald A; Bens S; Advani R; Barrans S; Copie-Bergman C; Elsensohn MH; Natkunam Y; Calaminici M; Sander B; Baia M; Smith A; Painter D; Pham L; Zhao S; Ziepert M; Jordanova ES; Molina TJ; Kersten MJ; Kimby E; Klapper W; Raemaekers J; Schmitz N; Jardin F; Stevens WBC; Hoster E; Hagenbeek A; Gribben JG; Siebert R; Gascoyne RD; Scott DW; Gaulard P; Salles G; Burton C; de Jong D; Sehn LH; Maucort-Boulch D
    J Clin Oncol; 2019 Dec; 37(35):3359-3368. PubMed ID: 31498031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Szczepanowski M; Baudis M; Bens S; de Leval L; Garcia-Orad A; Horn H; Lisfeld J; Pellissery S; Klapper W; Oschlies I; Siebert R
    Haematologica; 2013 Aug; 98(8):1237-41. PubMed ID: 23445872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.